India develops bio-nanocarrier to effectively treat visceral leishmaniasis

Indian researchers have developed a non-invasive, easy to administer, cost-effective, and patient compliant potential th...

August 16, 2021 | Monday | News
NZ links chronic lung diseases with heart attacks

People using two different inhalers for common chronic lung diseases are more than 50 per cent more likely to have a hea...

August 16, 2021 | Monday | News
Taiwan provides new information on pathogenesis of SARS-CoV-2 infection

A team of researchers at the National Institute of Infectious Diseases and Vaccinology in Taiwan is providing new i...

August 13, 2021 | Friday | News
Korea mimics atherosclerotic coronary artery using 3D-printing

A research team at Pohang University of Science and Technology (POSTECH) in South Korea has succeeded in mimicking the a...

August 12, 2021 | Thursday | News
China approves GC Pharma's GreenGene F as a therapy to treat Haemophilia A

China National Medical Products Administration (NMPA) has approved GC Pharma's GreenGene F (Beroctocog alfa) [Recom...

August 12, 2021 | Thursday | News
Singapore discovers small molecule inhibitors for COVID-19

Currently, the only treatment for COVID-19 approved by the US FDA is Remdesivir, but it has to be administered via intra...

August 11, 2021 | Wednesday | News
China discovers effective weight-loss method

A collaborative study between scientists at the Shanghai University of Traditional Chinese Medicine and AntiCancer Inc. ...

August 9, 2021 | Monday | News
Advanced Instruments to acquire Solentim to expand bioprocess workflows

Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing is set to acquire ...

August 6, 2021 | Friday | News
Lab-grown beating heart cells vulnerable to SARS-CoV-2 infection: Cambridge study

A team of scientists at the University of Cambridge (UK) has used human embryonic stem cells to grow clusters of heart c...

August 6, 2021 | Friday | News
UK firms to support Indian biotherapeutic companies with antibody development

Fusion Antibodies, pre-clinical antibody discovery, and development experts, and BioTickle, their exclusive distributor ...

August 6, 2021 | Friday | News
Australia initiates research on Ross River virus

The three-year project, between the University of Newcastle, Australia’s national science agency- Commonwealt...

August 6, 2021 | Friday | News
China identifies faecal bacterial markers for autism

The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine) reports a ground breaking discove...

August 5, 2021 | Thursday | News
Korea offers new insights into lung damage during COVID-19​

An immunology research team at the Korea Advanced Institute of Science and Technology (KAIST) has found that a...

August 5, 2021 | Thursday | News
NZ to establish new communicable diseases research centre

New Zealand (NZ)- based University of Otago’s Global Health Institute and Dunedin’s Mercy Hospital...

August 5, 2021 | Thursday | News
New drug delivers sight for sore eyes in Australia

A potential improved treatment for two of the leading causes of blindness – age and diabetes-related eye problems ...

August 4, 2021 | Wednesday | News
Australia lays focus on targeted treatments for triple negative breast cancer

The first award under BioCurate’s new “Proof of Concept” fund has been granted to Australia's Monash B...

August 3, 2021 | Tuesday | News
Precision biotherapeutics molecules at futuristic regimens: PROTAC & Undruggable Drug Targets

APAC is home to over 60% of the world’s population and the economical benefits of having a biopharma industry in t...

August 2, 2021 | Monday | Opinion
Taiwan links pelvic inflammatory disease with ovarian cancer in Asian women

A team of researchers at the China Medical University Hospital in Taiwan has sought to determine whether pelvic inf...

July 30, 2021 | Friday | News